Merck (NYSE:MRK) reported progress on its investigational oral PCSK9 inhibitor, enlicitide decanoate, including a ...
Codexis (NASDAQ:CDXS) reported first-quarter 2026 revenue of $15.2 million, up from $7.5 million a year earlier, as the company highlighted continued progress commercializing its ECO Synthesis ...
Detailed price information for Jazz Pharma Plc (JAZZ-Q) from The Globe and Mail including charting and trades.
An $80,000 annual income sits at a meaningful threshold. It roughly matches the combined Social Security benefit. It is ...
With an upside potential of 21.26% as of May 3, Merck & Co., Inc. (NYSE:MRK) is included among the 10 Best Fortune 500 Stocks ...
Dividend income arrives whether markets rally or sell off. For investors seeking recurring cash flow, high-yield equities ...
Futures are trading higher on Wednesday as news of an impending end to the Iran war is sending oil prices dramatically lower.
Merck, known as MSD outside of the United States and Canada, announced the successful completion of the acquisition of Terns Pharmaceuticals, Inc. (Terns). “The Terns acquisition reflects Merck’s ...
Merck (NYSE:MRK) delivered its fourth consecutive earnings beat, but shares slipped on the earnings report. With acquisition charges clouding the quarter, here is where the stock heads next. The 24/7 ...
Terns is now a wholly-owned subsidiary of Merck and its stock will no longer be listed or traded on the Nasdaq Global Select ...
Stroke drug developer Argenica Therapeutics plans a second trial to test its novel candidate, in a sector that has few ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results